Results 191 to 200 of about 11,764 (203)

Reduction of the angiostatic chemokine SF-1 and concomitant increase of its receptor CXCR-4 in colorectal cancer

Gastroenterology, 2000
Stefan Wildi, Jorg H. Kleeff, Haruhisa Maruyama, Helmut Friess, Christoph Maurer, Markus W. Buchler, Murray Korc   +6 more
openaire   +1 more source

The Specificity and Molecular Basis of α<SUB>1</SUB>-Adrenoceptor and CXCR Chemokine Receptor Dimerization

Journal of Molecular Neuroscience, 2005
Graeme Milligan, Shirley Wilson, Juan F. López-Gimenez   +2 more
openaire   +1 more source

Hesperidin suppresses the migration and invasion of non-small cell lung cancer cells by inhibiting the SDF-1/CXCR-4 pathway

Life Sciences, 2018
RongMu Xia, Xin Sheng, Hongling Lu
exaly  

CXCR5+CD8+ T cells present elevated capacity in mediating cytotoxicity toward autologous tumor cells through interleukin 10 in diffuse large B-cell lymphoma

International Immunopharmacology, 2017
Jie Zha, Pengcheng Shi, Bing Xu
exaly  

Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor Fusin/CXCR-4

Antiviral Research, 1997
Dominique Schols, José A Esté, Erik De Clercq   +2 more
exaly  

CXCR-4. a Co-Receptor for HIV-I. is Expressed in the Human Brain in a Variety of Cell Types Including Neurons and Microglia

Journal of Neuropathology and Experimental Neurology, 1997
E. Lavi, J. M. Strizki, A. M. Ulrich, W. Zhane, L. Fu, Q. Wang, M. OʼConnor, J. A. Hoxie, F. González-Searano   +8 more
openaire   +1 more source

Characterization of the prognostic values of CXCR family in gastric cancer

Cytokine, 2019
Chao-Ran Yu, Yujie Zhang
exaly  

CXCR5 + CD8 + T cells could induce the death of tumor cells in HBV-related hepatocellular carcinoma

International Immunopharmacology, 2017
exaly  

VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma

Annals of Oncology, 2013
exaly  

The WHIM-like CXCR4S338X somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom’s Macroglobulinemia

Leukemia, 2014
exaly